You are not currently logged in.
Access JSTOR through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Current Considerations in Heavy Charged-Particle Radiotherapy: A Clinical Research Trial of the University of California Lawrence Berkeley Laboratory, Northern California Oncology Group, and Radiation Therapy Oncology Group
J. R. Castro, G. T. Y. Chen and E. A. Blakely
Radiation Research Supplement
Vol. 8, Heavy Charged Particles in Research and Medicine. Proceedings of a Symposium Held at the Lawrence Berkeley Laboratory, University of California, Berkeley, California, May 1-3, 1985 (Nov., 1985), pp. S263-S271
Published by: Radiation Research Society
Stable URL: http://www.jstor.org/stable/3583536
Page Count: 9
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Phase I and II radiotherapy trials with accelerated high-energy heavy charged-particle beams have been carried out at the University of California Lawrence Berkeley Laboratory in conjunction with the Northern California Oncology Group and the Radiation Therapy Oncology Group. Clinical experience with several anatomical regions and tumor types has been accumulated. Preliminary observations suggest that toxicity is acceptable with treatment techniques developed for neon ions. Further data must be accumulated for carbon or silicon ion therapy. Initial Phase III trials with neon ions should begin shortly; evaluation of optimal ions and techniques for improved dose localization is ongoing. Future directions for optimization of heavy charged-particle radiotherapy are presented.
Radiation Research Supplement © 1985 Radiation Research Society